Table 1 Univariate and multivariate analyses for overall survival in PDAC patients.
Total (n = 130) | Univariate analysis | Multivariate analysis | |||
---|---|---|---|---|---|
Hazard ratio (95% CI) | p value | Hazard ratio (95% CI) | p value | ||
Age (years) (65≦65) | 100/30 | 1.50 (0.83–2.70) | 0.17 | ||
Gender (male/female)  | 64/66 | 1.22 (0.76–1.94) | 0.41 | ||
CA19-9 (500≦/<500 U/ml) | 96/34 | 2.06 (1.15–3.69) | 0.015* | 1.70 (0.96–3.01) | 0.07 |
Regional lymph node metastasis (+/−) | 91/39 | 2.21 (1.17–4.19) | 0.015* | 2.24 (1.22–4.10) | 0.009* |
Tumour volume (≥6283, <6283 mm3) | 71/59 | 3.60 (2.10–6.17) | <0.0001* | 2.31 (1.68–5.52) | 0.0002* |
C5a-C5aR1 c-axis (High/Low) | 48/82 | 1.89 (1.17–3.04) | 0.009* | 1.77 (1.02–3.07) | 0.04* |
C5a-C5aR2 c-axis (High/Low) | 70/60 | 0.62 (0.39–1.00) | 0.050 | 0.65 (0.91–2.57) | 0.11 |
C5a-C5aR1 s-axis (High/Low) | 51/79 | 2.22 (1.38–3.57) | 0.001* | 2.55 (1.51–4.30) | 0.0005* |